ORIGINAL RESEARCH article
Front. Nutr.
Sec. Nutritional Epidemiology
Volume 12 - 2025 | doi: 10.3389/fnut.2025.1662753
Association between serum 25-hydroxyvitamin D concentrations and platelet to high-density lipoprotein cholesterol ratio (PHR): Evidence from two population-based studies
Provisionally accepted
- Lu’an Hospital, Anhui Medical University, Hefei, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: The platelet to high-density lipoprotein cholesterol ratio (PHR) is an emerging marker of inflammation and metabolic health, combining platelet counts and HDL cholesterol (HDL-C) levels. Vitamin D is essential for various physiologic processes, including immune modulation and lipid metabolism. Our study investigates the association between serum 25-hydroxyvitamin D [25(OH)D] concentrations and PHR. Methods: We conducted cross-sectional analyses of two population-based datasets: NHANES (n = 36,238) from the U.S. and the baseline survey of a Chinese cohort study (n = 1,122). Serum 25(OH)D and blood PHR were assessed, with PHR defined as the ratio of platelet count to HDL-C (mmol/L). To examine the associations of 25(OH)D with PHR, we used weighted linear regression models and weighted restricted cubic splines (RCS), adjusting for potential confounders. Additionally, stratified analyses were performed based on potential influencing factors. Results: After stepwise adjusting for cycles, demographic characteristics, lifestyle factors, and health conditions (including medication use), survey-weighted linear regression analysis of the NHANES database identified a significant negative association of serum 25(OH)D levels with PHR. Specifically, for every 1-unit increase in 25(OH)D, PHR decreased by 0.23 to 0.41 units across models. This association remained significant when comparing the highest quartile (Q4) to the lowest quartile (Q1) of 25(OH)D, with PHR decreasing by 14.84 to 27.65 units across models. RCS analysis further supported a linear negative association of 25(OH)D with PHR. Similar results were observed for 25-hydroxyvitamin D3 [25(OH)D3]. Furthermore, analyses in the Chinese population confirmed the inverse association between serum total 25(OH)D and PHR. Notably, the stronger association observed in females was consistent across both populations, with statistically significant interaction effects. Conclusions: Our study found that serum 25(OH)D levels were significantly negatively correlated with PHR, particularly in females. These results suggest that 25(OH)D may help modulate PHR, with potential implications for disease prevention. Future research should confirm causality and explore underlying mechanisms.
Keywords: Vitamin D, 25-hydroxyvitamin D, PHR, Platelet to high-densitylipoprotein cholesterol ratio, Combined datasets
Received: 09 Jul 2025; Accepted: 19 Sep 2025.
Copyright: © 2025 Wang, Huang, Rao, Zhu, Cheng and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jun Zhu, wokey2001@163.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.